MicroBit Capital Announces US$100,000 Donation In Response to Tai Po Fire Tragedy
HONG KONG, Nov. 28, 2025 /PRNewswire/ — Following the devastating fire tragedy at Wang Fuk Court in Tai Po, which resulted in significant casualties and... Read more.
Yale-Trained Neuroscientist Unveils “Digital Sunshine” Device, Merging Ancient Eastern Wisdom with Modern Brain Science to Revolutionize Sleep
Panbrain Lume Offers a Drug-Free Path to Deeper Sleep and Faster Sleep Onset in Just 8 Minutes, Now Live on Kickstarter NEW HAVEN, Conn., Nov. 28, 2025 /PRNewswire/... Read more.
DB Group Expands Global Fintech Ecosystem with New Features, Awards, and Products
MAHE, Seychelles, Nov. 28, 2025 /PRNewswire/ — DB Group Holding Limited, a UAE-headquartered financial services firm, announces a series of major developments... Read more.
iQIYI Extends Theatrical Film Value with Cross-Platform Success of “The Shadow’s Edge”
BEIJING, Nov. 28, 2025 /PRNewswire/ — Recently, iQIYI, China’s leading online entertainment platform, announced the successful online release of its... Read more.
BCSC alleges multi-million dollar fraud, illegal distribution by B.C. corporation
VANCOUVER, BC, Nov. 28, 2025 /CNW/ – The BC Securities Commission (BCSC) is alleging that a B.C. corporation and two individuals contravened the Securities... Read more.
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene’s onCARlytics... Read more.
JMGO Advances North American Market Strategy Through New Presence on Costco
SHENZHEN, China, Nov. 27, 2025 /PRNewswire/ — JMGO, a pioneer in optical technology, announced its official cooperation with Costco in North America. Currently,... Read more.
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma
CHENGDU, China, Nov. 27, 2025 /PRNewswire/ — On November 25, 2025, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”,... Read more.
CCTV+: Liangzhu and the World: Dialogues that Illuminate the Future!
The Global Premiere of the Documentary “Liangzhu: A Dialogue across World Civilizations” BEIJING, Nov. 27, 2025 /PRNewswire/ — To advance the Global... Read more.
ALLUONE Launches Customized Solution as the Plant-Care Market Continues to Grow
SEOUL, South Korea, Nov. 27, 2025 /PRNewswire/ — As “pet plants” emerge as a new healing trend following the rise of pet ownership, ALLUONE is... Read more.